The novel treatment of the medication represents a significant development in the management of type 2 diabetes. Different to existing drugs, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide306682.idblogmaker.com/40709210/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment